Search results for "Drugs"

showing 10 items of 747 documents

Rare diseases and orphan drugs: Latvian story

2014

Background Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries. Methods We used the national plan for rare diseases, EUCERD reports, Orphanet data, Latvian and European regulations, publicly availa…

medicine.medical_specialtyEconomic growthNational Health ProgramsOrphan Drug ProductionLegislationReviewPharmacologyOrphan drugRare DiseasesPolitical scienceOrphan Drug ProductionHealth caremedicineMember stateHumansOrphan drugsGenetics(clinical)Pharmacology (medical)Genetics (clinical)Medicine(all)business.industryPublic healthLatvianAvailabilityLegislatureGeneral MedicineLegislation DrugAccessibilityLatvialanguage.human_languageEuropelanguagebusinessOrphanet Journal of Rare Diseases
researchProduct

Air pollution exposure during pregnancy and reduced birth size: a prospective birth cohort study in Valencia, Spain

2010

Abstract Background Maternal exposure to air pollution has been related to fetal growth in a number of recent scientific studies. The objective of this study was to assess the association between exposure to air pollution during pregnancy and anthropometric measures at birth in a cohort in Valencia, Spain. Methods Seven hundred and eighty-five pregnant women and their singleton newborns participated in the study. Exposure to ambient nitrogen dioxide (NO2) was estimated by means of land use regression. NO2 spatial estimations were adjusted to correspond to relevant pregnancy periods (whole pregnancy and trimesters) for each woman. Outcome variables were birth weight, length, and head circumf…

medicine.medical_specialtyEmbarazoBirth weightHealth Toxicology and MutagenesisNitrogen Dioxidelcsh:RC963-969PregnancyEstudios prospectivosmedicine:Chemicals and Drugs::Chemical Actions and Uses::Toxic Actions::Environmental Pollutants::Air Pollutants [Medical Subject Headings]:Health Care::Environment and Public Health::Public Health::Environmental Pollution::Environmental Exposure::Maternal Exposure [Medical Subject Headings]Birth WeightBody SizeHumansContaminantes del aireProspective StudiesProspective cohort study:Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Reproduction::Pregnancy [Medical Subject Headings]Vehicle Emissions:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]PregnancyAir PollutantsInhalation Exposurebusiness.industryObstetricslcsh:Public aspects of medicineResearchPublic Health Environmental and Occupational HealthInfant Newbornlcsh:RA1-1270Odds ratioAnthropometrymedicine.disease:Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Prospective Studies [Medical Subject Headings]Exposición maternaMaternal ExposureSpainCohortInfant Small for Gestational Agelcsh:Industrial medicine. Industrial hygieneSmall for gestational ageFemaleValenciabusinessCohort studyEnvironmental Monitoring
researchProduct

Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.

2013

Psychiatry is increasingly combining new pharmacogenomic findings with therapeutic drug monitoring (TDM) to improve the safety and efficacy of pharmacotherapy. However, a distinction should be made between “nice to know” and “need to know” pharmacogenomic data because many results are statistically significant in meta-analyses but are not clinically relevant due to their low effect sizes. Some examples will illustrate this integration.

medicine.medical_specialtyGenotypeAlternative medicineNicePharmacotherapyNeed to knowmedicineGenomic medicineAnimalsHumansPharmacology (medical)Precision MedicinePsychiatrycomputer.programming_languagePharmacologyPsychiatryPsychotropic Drugsmedicine.diagnostic_testbusiness.industryMental DisordersTherapeutic drug monitoringPharmacogeneticsPharmacogenomicsDrug MonitoringbusinesscomputerClinical pharmacology and therapeutics
researchProduct

Effects of an Educational Program for Professional Caregivers on Behavioral Alterations in Nursing Home Residents: Pilot Study

2020

This pilot study aims to analyze the effectiveness of a type of non-pharmacological intervention such as the educating and training of professional caregivers on behavioral alterations and prescription of psychotropic drugs of older adults in nursing homes. One hundred and forty-five people from two nursing homes were randomized to either treatment (educational training program for healthcare professionals) or a no-treatment group. Twenty-two professional caregivers in the experimental group received 20 h of a training program. Five data collection points were collected (pre and post, and three follow-ups, all six months apart). Intervention consisted of the behavioral alterations and psych…

medicine.medical_specialtyHealth Toxicology and MutagenesisHealth PersonnelFarmacologíaeducationAncianoPsychological interventionlcsh:MedicinePilot ProjectsArticleEducation03 medical and health sciences0302 clinical medicineBehavior TherapyIntervention (counseling)DemenciamedicineDementiaHumans030212 general & internal medicinePsicofarmacologíaMedical prescriptioncaring professionalsAgedInvestigación psicológicapsychopharmacologyPsychotropic Drugsbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthRepeated measures designmedicine.diseaseNursing Homesnursing homebehavioural alterationsCaregiversFamily medicineDementiaTraining programNursing homesbusinessHogares para ancianosEducational program030217 neurology & neurosurgery
researchProduct

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of …

2017

Abstract The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn’s disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases.

medicine.medical_specialtyIBDDiseaseGuidelineGuidelinesInflammatory bowel diseaseGastroenterologyBiological drugs03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineMedicalmedicineCorticosteroidCorticosteroidsHumansIn patient030212 general & internal medicineCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Hepatology; GastroenterologySocieties MedicalCrohn's diseaseSettore MED/12 - GastroenterologiaUlcerative colitiHepatologybusiness.industryImmunosuppressorsRemission InductionGastroenterologyInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesClinical PracticeCrohn's diseaseUlcerative colitisItalyImmunosuppressorCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Adrenal Cortex Hormones; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Italy; Remission Induction; Societies Medical030211 gastroenterology & hepatologybusinessSocietiesImmunosuppressive Agents
researchProduct

Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis

2017

medicine.medical_specialtyImmunologyDisease03 medical and health sciencesPsoriatic arthritis0302 clinical medicineHumansImmunology and AllergyMedicineSpondylitis AnkylosingMolecular Targeted TherapyProtein Kinase Inhibitors030203 arthritis & rheumatologyClinical Trials as TopicTofacitinibbusiness.industrymedicine.diseaseDermatologyOncologyNilotinibAntirheumatic Agents030220 oncology & carcinogenesisApremilastbusinessAntirheumatic drugsmedicine.drugImmunotherapy
researchProduct

Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease

2013

AbstractThe natural history of Crohn's Disease and ulcerative colitis is characterized by repeated episodes of inflammation and ulceration of the bowel. This results in complications implying a worse quality of life and significant healthcare costs, due to hospitalization, surgery and an escalation of therapy.The main goal of the therapy in inflammatory bowel disease is to achieve and maintain disease remission, with an improved health-related quality of life, less hospitalization, and less surgery. The concept of remission has changed in the recent years. In fact the concept of clinical remission, where only the patients’ symptoms are in remission, has been replaced by the new concept of d…

medicine.medical_specialtyInflammationDiseaseClinical remissionInflammatory bowel diseaseGastroenterologyEndoscopy GastrointestinalMaintenance ChemotherapyBiological drugsCrohn DiseaseQuality of lifeRecurrenceInternal medicinemedicineHumansIntestinal MucosaWound HealingHepatologybusiness.industryMucosal healingInflammatory Bowel DiseaseRemission InductionGastroenterologymedicine.diseaseUlcerative colitisNatural historyMucosal healingColitis Ulcerativemedicine.symptombusinessDigestive and Liver Disease
researchProduct

Can eastern wisdom resolve western epidemics? Traditional Chinese medicine therapies and the opioid crisis.

2020

The widespread use of opioids to treat chronic pain led to a nation-wide crisis in the United States. Tens of thousands of deaths annually occur mainly due to respiratory depression, the most dangerous side effect of opioids. Non-opioid drugs and non-pharmacological treatments without addictive potential are urgently required. Traditional Chinese medicine (TCM) is based on a completely different medical theory than academic Western medicine. The scientific basis of acupuncture and herbal treatments as main TCM practices has been considerably improved during the past two decades, and large meta-analyses with thousands of patients provide evidence for their efficacy. Furthermore, opinion lead…

medicine.medical_specialtyModalitiesbusiness.industryChronic painAcupuncture TherapyGeneral MedicineTraditional Chinese medicinemedicine.diseaseUnited StatesScientific evidenceClinical trialAnalgesics OpioidOpioidAcupunctureMedicineHumansMedicine Chinese TraditionalOpioid EpidemicbusinessIntensive care medicineEpidemicsDepression (differential diagnoses)medicine.drugDrugs Chinese HerbalJournal of integrative medicine
researchProduct

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

2014

Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psychotherapy or a combination of both methods. The data from literature show that those treatment methods lead to an improvement of clinical symptoms, but they exert a possible impact on cognitive functions. However the study results referring both to the role of pharmacological treatment and psychotherapy in this domain are still inconsistent. There is an increasing number of accessible data confirm…

medicine.medical_specialtyNeurologyClinical NeurologyPsychological interventionAnxietyPsychiatry and Preclinical Psychiatric Studies - Review articlemedicineHumansApathyCognitive skillPsychiatryBiological PsychiatryPsychotropic DrugsDepressionAnhedoniaCognitionAnxiety DisordersDatabases BibliographicPharmacotherapyCognitive functionsPsychotherapyPsychiatry and Mental healthNeurologyAnxietyNeurology (clinical)medicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologyJournal of Neural Transmission : Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies
researchProduct

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

2021

Objective: To identify baseline factors associated with disease activity in patients with relapsing–remitting multiple sclerosis (RRMS) under teriflunomide treatment. Methods: This was an independent, multi-centre, retrospective post-marketing study. We analysed data of 1,507 patients who started teriflunomide since October 2014 and were regularly followed in 28 Centres in Italy. We reported the proportions of patients who discontinued treatment (after excluding 32 lost to follow-up) and who experienced clinical disease activity, i.e., relapse(s) and/or confirmed disability worsening, as assessed by the Expanded Disability Status Scale (EDSS). Decision tree-based analysis was performed to i…

medicine.medical_specialtyNeurologyMultiple SclerosisToluidinesHydroxybutyratesOral drugsDiseaseRelapsing-RemittingSettore MED/26Pregnancy planning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMultiple Sclerosis Relapsing-RemittingInternal medicineTeriflunomideTeriflunomideNitrilesmedicineHumans030212 general & internal medicineAdverse effectRetrospective StudiesExpanded Disability Status Scalebusiness.industryMultiple sclerosismedicine.diseaseSettore MED/26 - NEUROLOGIANeurologychemistryTolerabilityItalyMultiple sclerosis; Oral drugs; Teriflunomide; Crotonates; Humans; Hydroxybutyrates; Italy; Nitriles; Retrospective Studies; Toluidines; Multiple Sclerosis; Multiple Sclerosis Relapsing-RemittingCrotonatesNeurology (clinical)business030217 neurology & neurosurgeryJournal of neurology
researchProduct